2021 annual financial data
Dogwood Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -15,640,940 USD and net income was -15,960,268 USD.
Operating cash flow was -15,689,578 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,640,940 USD
- Net income
- -15,960,268 USD
- Operating cash flow
- -15,689,578 USD